Alain B. Tchagang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alain B. Tchagang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed H. Tewfik
Department of Electrical & Computer Engineering, University of Minnesota, Minneapolis, MN 55455, USA
2 shared publications - Amy P. N. Skubitz
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
2 shared publications Ahmed H. Tewfik
Electrical and Computer Engineering
1 shared publicationKeith M. Skubitz
Medicine, University of Minnesota, Minneapolis, Minnesota
1 shared publication- Keith M. Skubitz
University of Minnesota Minneapolis Minnesota USA
1 shared publication Melissa S. DeRycke
Laboratory Medicine and Pathology, and
1 shared publication
Latest Publications
- 1 January 2008
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 7 (1) , 27-37
Early detection of ovarian cancer using group biomarkers
One reason that ovarian cancer is such a deadly disease is because it is not usually diagnosed until it has reached an advanced stage. In this study, we developed a novel algorithm for group biomarkers identification using gene expression data. Group biomarkers consist of coregulated genes across normal and different stage diseased tissues. Unlike prior sets of biomarkers identified by statistical methods, genes in group biomarkers are potentially involved in pathways related to different types of cancer development. They may serve as an alternative to the traditional single biomarkers or combination of biomarkers used for the diagnosis of early-stage and/or recurrent ovarian cancer. We extracted group biomarkers by applying biclustering algorithms that we recently developed on the gene expression data of over 400 normal, cancerous, and diseased tissues. We identified several groups of coregulated genes that encode for secreted proteins and exhibit expression levels in ovarian cancer that are at least 2-fold (in log2 scale) higher than in normal ovary and nonovarian tissues. In particular, three candidate group biomarkers exhibited a conserved biological pattern that may be used for early detection or recurrence of ovarian cancer with specificity greater than 99% and sensitivity equal to 100%. We validated these group biomarkers using publicly available gene expression data sets downloaded from a NIH Web site (http://www.ncbi.nlm.nih.gov/geo). Statistical analysis showed that our methodology identified an optimum combination of genes that have the highest effect on the diagnosis of the disease compared with several computational techniques that we tested. Our study also suggests that single or group biomarkers correlate with the stage of the disease. [Mol Cancer Ther 2008;7(1):27–37]
- 1 January 2008
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 7 (1) , 27-37
Early detection of ovarian cancer using group biomarkers
One reason that ovarian cancer is such a deadly disease is because it is not usually diagnosed until it has reached an advanced stage. In this study, we developed a novel algorithm for group biomarkers identification using gene expression data. Group biomarkers consist of coregulated genes across normal and different stage diseased tissues. Unlike prior sets of biomarkers identified by statistical methods, genes in group biomarkers are potentially involved in pathways related to different types of cancer development. They may serve as an alternative to the traditional single biomarkers or combination of biomarkers used for the diagnosis of early-stage and/or recurrent ovarian cancer. We extracted group biomarkers by applying biclustering algorithms that we recently developed on the gene expression data of over 400 normal, cancerous, and diseased tissues. We identified several groups of coregulated genes that encode for secreted proteins and exhibit expression levels in ovarian cancer that are at least 2-fold (in log2 scale) higher than in normal ovary and nonovarian tissues. In particular, three candidate group biomarkers exhibited a conserved biological pattern that may be used for early detection or recurrence of ovarian cancer with specificity greater than 99% and sensitivity equal to 100%. We validated these group biomarkers using publicly available gene expression data sets downloaded from a NIH Web site (http://www.ncbi.nlm.nih.gov/geo). Statistical analysis showed that our methodology identified an optimum combination of genes that have the highest effect on the diagnosis of the disease compared with several computational techniques that we tested. Our study also suggests that single or group biomarkers correlate with the stage of the disease. [Mol Cancer Ther 2008;7(1):27–37]
- 1 June 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21503001,p. 1-4
Distributed Robust Biclustering Algorithm for Gene Expression Analysis
Show by Cheng and Church to be an NP-complex problem, biclustering algorithms are more complex than the classical one dimensional clustering technique, particularly requiring multiple computing platforms for large and distributed datasets. In this study, we proposed and extension of the robust biclustering algorithm (RoBA) that is capable of performing biclustering on extremely large or geographically distributed set of gene expression data. The distributed version will divide the cluster tasks among A' processors with negligible communication costs thus making it scalable over large number of computing nodes. The proposed algorithm has been implemented using Matlab MPI and the performance results are reported based on executions on a 1, 2, 3, 4, and 5 nodes Windows PC cluster connected over 100 Mbits links. The experimental results show increased performance with the increased number of nodes on the same set of data.
- 1 June 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 21503001,p. 1-4
Distributed Robust Biclustering Algorithm for Gene Expression Analysis
Show by Cheng and Church to be an NP-complex problem, biclustering algorithms are more complex than the classical one dimensional clustering technique, particularly requiring multiple computing platforms for large and distributed datasets. In this study, we proposed and extension of the robust biclustering algorithm (RoBA) that is capable of performing biclustering on extremely large or geographically distributed set of gene expression data. The distributed version will divide the cluster tasks among A' processors with negligible communication costs thus making it scalable over large number of computing nodes. The proposed algorithm has been implemented using Matlab MPI and the performance results are reported based on executions on a 1, 2, 3, 4, and 5 nodes Windows PC cluster connected over 100 Mbits links. The experimental results show increased performance with the increased number of nodes on the same set of data.
- 1 January 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 1, I-341-I-344
Group-Biomarkers Identification in Ovarian Carcinoma
In this paper, we propose group-biomarkers as an alternative to the traditional single biomarkers used to date for the detection of ovarian cancer. Group-biomarkers are a set of genes that are used simultaneously for the diagnosis of early-stage and/or recurrent cancer. We describe a procedure for identifying such group-biomarkers from a data set of gene expression levels corresponding to normal and diseased ovarian tissue as well as tissue from other organs. The procedure starts with a list of potential single biomarkers. It then uses an order preserving biclustering step to identify other genes that are co-regulated with the candidate single biomarkers across the normal and diseased ovarian tissue and tissue from other organ. We present a statistical analysis that demonstrates that group-biomarkers have a much better detection performance than single biomarkers as exhibited by receiver operating characteristics curves.
- 1 January 2007
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 1, I-341-I-344
Group-Biomarkers Identification in Ovarian Carcinoma
In this paper, we propose group-biomarkers as an alternative to the traditional single biomarkers used to date for the detection of ovarian cancer. Group-biomarkers are a set of genes that are used simultaneously for the diagnosis of early-stage and/or recurrent cancer. We describe a procedure for identifying such group-biomarkers from a data set of gene expression levels corresponding to normal and diseased ovarian tissue as well as tissue from other organs. The procedure starts with a list of potential single biomarkers. It then uses an order preserving biclustering step to identify other genes that are co-regulated with the candidate single biomarkers across the normal and diseased ovarian tissue and tissue from other organ. We present a statistical analysis that demonstrates that group-biomarkers have a much better detection performance than single biomarkers as exhibited by receiver operating characteristics curves.